Navigation Links
Endo Pharmaceuticals Holdings Inc. Announces Pricing of Private Offering of Senior Notes
Date:11/18/2010

ents to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. You should understand that these statements are not guarantees of performance or results and are preliminary in nature. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "intend," "guidance" or similar expressions are forward-looking statements. Because these statements reflect our current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties.

You should consider the areas of risk described under the heading "Forward-Looking Statements" and "Risk Factors" in Endo's periodic reports filed with the Securities and Exchange Commission under the Exchange Act and those risk factors included as "Item 1A. Risk Factors" in Endo's Quarterly Report on Form 10-Q for the three months ended September 30, 2010, as updated by the risk factors set forth in any subsequent filing by Endo with the Securities and Exchange Commission, in connection with any forward-looking statements that may be made by Endo generally. Except for ongoing obligations to disclose material information under the federal securities laws, Endo undertakes no obligation to release publicly any updates or revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events unless required by law.


'/>"/>
SOURCE Endo Pharmaceuticals Holdings Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015 The nuclear ... by 2020 at a CAGR of 12.08%. Nuclear medicine ... diseases. The two major types of Nuclear imaging used ... was the mainstream modality for nuclear medicine applications like ... to change because of global shortage of molybdenum-99 isotope ...
(Date:6/1/2015)... About Pressure Relief Devices ... and improve the quality life of patients who suffer ... a significant role in inhibiting the growth and treatment ... turn or rotate an immobile patient by providing all ... and specialty beds. These devices have the ability to ...
(Date:6/1/2015)... June 1, 2015 Select Medical Holdings Corporation ... Corporation, a joint venture that Select Medical Corporation ("Select") ... completed its previously announced acquisition of Concentra Inc.  Cressey ... venture. About Select Medical Corporation ... hospitals and outpatient rehabilitation clinics in the ...
Breaking Medicine Technology:North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 2North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 3Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 2Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 3
... Nov. 3 WebMD Health Corp. (Nasdaq: WBMD ) announced ... to purchase up to 5,700,000 shares of its common stock at ... price per share of WebMD,s common stock on the Nasdaq Global ... The number of shares proposed to be purchased in the tender ...
... , SAN DIEGO, Nov. 3 Robert Mazzacavallo has ... Diego-based Veridiam is a contract manufacturer of high-precision, fabricated ... in the medical devices, power generation, aerospace and general ... Financial Officer at C-Tech Industries in Camas, WA. ...
Cached Medicine Technology:WebMD Health Corp. Announces Intention To Commence Tender Offer To Repurchase Up To 5,700,000 Shares of its Common Stock 2WebMD Health Corp. Announces Intention To Commence Tender Offer To Repurchase Up To 5,700,000 Shares of its Common Stock 3Veridiam Names Robert Mazzacavallo New CFO 2
(Date:6/1/2015)... 01, 2015 There’s never a good time ... comes to non-emergency, minor illnesses. , As of June 1, ... access to medical care via the Internet. Patients throughout Illinois ... or computer. , “Everyone is busy. We know that getting ... so we want to make it easier,” said Jeffry Tillery, ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Listen to ... established automotive companies are using more granular data to ... two comparatively new industry voices in Josep Celaya Gonzalez, ... winning start-up ParkTAG. As an automotive insurer, MAPFRE are ... as an easy-to-use solution to the driver. Award winning ...
(Date:6/1/2015)... InstantLabs will co-develop and commercialize a ... a Cooperative Research and Development Agreement (CRADA) with the ... with U.S. Farm Bill legislation, only members of the ... the United States. , InstantLabs’ DNA-based technology will ... need rather than requiring samples be sent to centralized ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 This is ... Annual GrowRIVERSIDE Conference: The Future of Local Food, June ... conference will assist cities in examining and ... urban agriculture infrastructure. , Organized for the city of ... feature a broad lineup of speakers ranging from urban ...
(Date:6/1/2015)... Strategic Radiology (SR) announced today that Rome Radiology ... the SR coalition of progressive, independent radiology groups geographically ... now have access to collective resources in all aspects ... deployment of subspecialized radiology services. With the addition of ... US based radiology group practices. , “We are ...
Breaking Medicine News(10 mins):Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:Complimentary Webinar: Volvo, MAPFRE and Award Winning Start-Up discuss new Frontier of In-Car Services 2Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 2Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 3Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 4Health News:Limited Tickets Available for “GrowRIVERSIDE” Conference June 11 2Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 2Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 3Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 4
... 4th Leading Cause of Death in U.S., SWANTON, ... Awareness Month, to help raise awareness about Chronic,Obstructive Pulmonary ... AllerAir will be making downloadable,tips available to COPD patients ... their November newsletter and blogs to raising awareness,about this ...
... TORONTO, Nov. 3 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc.,a ... cancer therapies, announced today that Dr. Alan M.,Ezrin, ... will present a,corporate update at Rodman & Renshaw ... New York City from November 10th - 12th ...
... /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. (TSX: PMD; PREMF.pk) ... Exchange ("TSX") that it is reviewing the eligibility of ... The Company is being reviewed under the TSX,s ... comply with all requirements for continued,listing. If the Company ...
... cash flow from operations, updated guidance, and new stock ... ... (Nasdaq: AMCS ), a,leader in radiology and medical image and ... ended,September 30, 2008., (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ...
... out than those without deployed kin , , MONDAY, Nov. 3 ... Iraq and Afghanistan are more likely to have behavioral problems ... , Researchers studied 169 families with children aged 18 months ... at a Marine base. , Of those families, 55 (33 ...
... Cox-1 drugs, like naproxen, study says , , MONDAY, Nov. ... attack that comes with the use of nonsteroidal anti-inflammatory ... to the specific pain-causing molecule they act against, a ... between the degree of inhibition in vitro [in the ...
Cached Medicine News:Health News:AllerAir Dedicates November to COPD Awareness Month 2Health News:Bradmer to present at Rodman & Renshaw Healthcare Conference 2Health News:Bradmer to present at Rodman & Renshaw Healthcare Conference 3Health News:Listing Review initiated by the Toronto Stock Exchange 2Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 2Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 3Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 4Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 5Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 6Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 7Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 8Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 9Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 10Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 11Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 12Health News:Kids With Parent in War Zone Face Behavior Risks 2Health News:Study Sheds Light on Painkillers' Heart Risk 2Health News:Study Sheds Light on Painkillers' Heart Risk 3